DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Llovet JM, Ricci S, Mazzaferro V , et al.
Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): results of a Phase III randomized placebo-controlled trial (SHARP trial).
Paper presented at: American Society of Clinical Oncology Annual Meeting; June 1–5, 2007; Chicago, IL

Download Bibliographical Data

Search in: